Mitotane, is a steroidogenesis inhibitor and cytostatic antineoplastic medication which is used in the treatment of adrenocortical carcinoma and Cushing’s syndrome. It is a derivative of the early insecticide DDT and an isomer of p,p’-DDD (4,4′-dichlorodiphenyldichloroethane) and is also known as 2,4′-(dichlorodiphenyl)-2,2-dichloroethane (o,p’-DDD).<\/p>\n
Mitotane, is used to treat the symptoms of advanced adrenal cortical carcinoma (cancer of the outer layer of the adrenal gland). It is used when the cancer is unresectable (cannot be removed by surgery), is metastatic (has spread to other parts of the body), or has relapsed (returned after treatment).<\/p>\n
If Mitotane tablets tablets are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n","protected":false},"excerpt":{"rendered":"
mitotane is an adrenal cytotoxic agent indicated for the treatment of inoperable, functional or nonfunctional, adrenal cortical carcinoma.<\/p>\n
Approval Date:<\/strong> 1970 If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import \u201cMitotane tablets\u201d based on the information you provide.<\/p>\n
\nProprietary Name:<\/strong> On Request
\nActive Ingredient(s):<\/strong> Mitotane tablets
\nDosage Forms And Strengths: Tablets: 500 mg, scored<\/strong>
\nManufacturer: Bristol-Myers Squibb Company\u00a0<\/strong>
\nMedicine Approved By: –<\/strong> European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
\nSummary of FDA approved use on approval date:\u00a0<\/strong>Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n